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Objective: Active transcutaneous bone conduction devices consist of an external audio
processor and an internal implant under intact skin. During the surgical procedure, it is
important to verify the functionality of the implant before the surgical wound is closed. In
a clinical study with the new bone conduction implant (BCI), the functionality of the implant
was tested with an electric transmission test, where the output was the nasal sound pressure
(NSP) recorded in the ipsilateral nostril. The same measurement was performed in all follow-
up visits to monitor the implant's functionality and transmission to bone over time. The
objective of this study was to investigate the validity of the NSP method as a tool to
objectively verify the implant's performance intraoperatively, as well as to follow-up the
implant's performance over time.
Design: Thirteen patients with the BCI were included, and the NSP measurement was part
of the clinical study protocol. The implant was electrically stimulated with an amplitude-
modulated signal generator using a swept sine 0.1–10 kHz. The NSP was measured with
a probe tube microphone in the ipsilateral nostril.
Results: The NSP during surgery was above the noise ﬂoor for most patients within the
frequency interval 0.4–5 kHz, showing NSP values for expected normal transmission of
a functioning implant. Inter-subject comparison showed large variability, but follow-up
results showed only minor variability within each subject. Further investigation showed
that the NSP was stable over time.
Conclusion: The NSP method is considered applicable to verify the implant's functionality
during and after surgery. Such a method is important for implantable devices, but should be
simpliﬁed and clinically adapted. Large variations between subjects were found, as well as
smaller variability in intra-subject comparisons. As the NSP was found to not change
signiﬁcantly over time, stable transmission to bone, and implant functionality, were
indicated.
Keywords: bone conduction, nasal sound pressure, bone conduction implant, ear-canal
sound pressure, objective intraoperative veriﬁcation
Introduction
Bone conduction devices (BCDs) are used to rehabilitate patients with conductive
or mixed hearing loss. Lately, several alternatives of transcutaneous BCDs have
been developed and introduced to the market. These are composed of external and
internal parts with intact skin in-between. In passive transcutaneous BCDs, the
internal part consists solely of one or two bone-anchored magnets in a titanium
casing, while in active transcutaneous BCDs, the internal part includes a magnet
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plus a vibrating transducer, and the signal is electromag-
netically transmitted through the skin, rather than
mechanically transmitted.1 During implantation of these
devices, it is important to check the functionality of the
internal part before closing the surgical wound.
The bone conduction implant (BCI) is a new active
transcutaneous BCD in an ongoing multicenter clinical
trial.2–4 It consists of an external audio processor and an
internal implant. The signal is electromagnetically trans-
ferred over the skin via an induction link, and the implant
includes a retention magnet, a receiving coil,
a demodulator, and a transducer.5 The type of transducer
is a balanced electromagnetic separation transducer, to
minimize the size, increase the efﬁciency, and decrease
distortion.6 In the clinical trial, 16 patients have been
included so far (13 in Gothenburg and three in
Stockholm). The protocol with follow-up visits spans
over a period of 5 years after ﬁtting of the audio processor
and includes several measurements, such as audiometric
tone and speech tests, questionnaires, cone beam com-
puted tomography, retention force, electric transmission,
and output force level measurements.
During the surgery, a veriﬁcation of the functionality of
the implant is needed in order to avoid unnecessary post-
operative revisions of the implant. As the patient is
anesthetized during the whole surgical procedure, an
objective measurement not requiring active participation
by the patient is the only alternative. Furthermore, the
implant needs to be stimulated in a controlled way in
order to assess the quality of the response. An amplitude-
modulated driver stage was developed to electrically sti-
mulate the implanted transducer through the induction link
over the skin.
In case of correct functioning of the implanted compo-
nents, vibrations are transmitted to the skull bone and can
therefore be recorded as vibrations in the surrounding tissue
or as sound pressure in cavities of the skull. Few studies
have been done on how to easily and reliably verify the
transmission properties of implantable devices through laser
Doppler vibrometer (LDV) and probe tube microphone
measurements. In a study by Winter et al,7 the ear canal
sound pressure (ECSP) level was found to be an effective
way to verify the correct positioning and activation of the
Symphonix Vibrant® Soundbridge (VSB) middle ear
implant, intra- as well as postoperatively. In their study,
the authors validated microphone measurements against
vibrational LDV measurements of the stapes motion, ﬁnd-
ing a very high correlation, and extended the use of their
method as a guideline for the ﬁtting procedure of the VSB
in follow-up visits.8 A modiﬁed version of the same tech-
nique was later developed by Schnabl et al9 and applied to
the veriﬁcation of mechanical coupling and functional
integrity during the surgical implantation of the active trans-
cutaneous BCD Bonebridge® (Vibrant MED-EL,
Innsbruck, Austria). In their measurement setup, the audio
processor was acoustically stimulated with test tones and
sound pressure was measured with a microphone perpendi-
cularly taped on the skin in the middle section of the fore-
head. In a recent study by Ghoncheh et al,10 both LDV and
microphone measurements were performed during surgery
for the same transcutaneous BCD implantation. In their
study, Ghoncheh et al used LDV at the implant surface
and adjacent bone just after the implant ﬁxation, while the
ECSP level was measured at the opening of both ear canals
after closing of the surgical wound. Despite a very high
inter-patient variability, the two measurements were found
to correlate well at a group level and the authors concluded
that an ECSP measurement can be a reliable tool for implant
veriﬁcation.
Even though ECSP has been shown to have good
potential as a veriﬁcation tool, major limitations to the
application of this method exist: 1) not all BCD patients
have external ear canals, 2) during surgery, the pinna is
folded over the ipsilateral ear canal, 3) the area around the
ear being operated on is sterile, and 4) the contralateral ear
canal is often barely accessible due to lateral head rest
position of the anesthetized patient. Therefore, in this
article, another cavity is addressed as an alternative to
the ear canal – the nasal cavity.
In a preclinical study, nasal sound pressure (NSP) was
investigated in 20 normal-hearing subjects and compared
to the ear canal sound pressure.11 It was found that the
NSP gave higher signal-to-noise ratio than the ear canal
sound pressure from the same stimulation. Both ipsilateral
and contralateral measurements were made from two sti-
mulation positions behind the ear. It was also found that it
is appropriate to measure 8 mm into the ipsilateral nostril,
to let the patient hold their breath during the measurement,
and to completely plug the ipsilateral nostril.
So far in the clinical study, the electric transmission
test with NSP has been used on all 13 patients in
Gothenburg. The data from the surgery and from the
follow-up visits have been compiled in this study to assess
whether this is a feasible way of verifying the implant's
functionality, and to investigate inter- and intra-subject
variations and change over time.
Reinfeldt et al Dovepress
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Aim of the study
The aim of this study was to investigate:
(a) the potential of the NSP measurement as objective
veriﬁcation of the implant's functionality, in parti-
cular during surgery;
(b) the inter- and intra-subject variability in NSP
values;
(c) the stability of NSP over time.
Materials and methods
Subjects
Test subjects were patients with the BCI implanted in
Gothenburg between December 2012 and
November 2016 in the clinical study. This clinical study
was approved by the Swedish Medical Agency and
Regional Ethics Committee in Gothenburg, and all patients
signed informed consent prior to inclusion; hence, the
study was conducted in accordance with the Declaration
of Helsinki. Measurement of NSP was done as part of the
protocol to verify the implant's functionality during sur-
gery and follow-up visits for the 13 patients included in
Gothenburg. Data on two follow-up visits are missing, 12
months for patient 3, and 3 months for patient 6.
Measurement setup
The measurement setup is illustrated in Figure 1. With the
BCI implant in place, the transmitter coil was placed over
the skin aligned to the receiver coil in the implant. The
inductive link was driven by using an Agilent 35670A
(Keysight Technologies, Santa Rosa, CA, USA) as a fast
Fourier transform analyzer and speech frequency signal
generator, and an Agilent 33220A (Keysight
Technologies) as a carrier frequency and amplitude mod-
ulation signal generator. Together, the transmitter induc-
tive link, the Agilent 35670A, and the Agilent 33220A are
referred to as the amplitude-modulated driver stage. With
the implant fully functioning, the transducer is transmitting
vibrations through the skull bone, and sound is radiated
into cavities of the skull, such as the nostrils. The NSP was
measured by inserting a small probe tube through an EAR
Classic ear-plug (3M, Maplewood, MN, USA) in the ipsi-
lateral nostril. The probe tube was attached to an omni-
directional microphone (EM-23346, Knowles Electronics,
Itasca, IL, USA) with a battery-operated low noise linear
pre-ampliﬁer (Gennum LC506, Semtech Corp, Camarillo,
CA, USA). The frequency response of the NSP was mea-
sured by the Agilent 35670A in the frequency range of
0.1–10 kHz.
Measurements
The ear-plug was inserted 8 mm into the ipsilateral nostril.
The further in, the higher the sound pressure; however, it
should be at a depth which minimizes the risk of the probe
tube touching internal walls of the nasal cavity.
Measurements on normal-hearing subjects in a pilot
Ch2Ch1
Source
Output
Modulation In
Agilent 33220A
Agilent 35670A
Receiver Inductive LinkUSB/GBIP Interface
Implanted Bone 
Conduction Transducer
& Demodulation Unit
Transmitter Inductive Link
Microphone
Laptop
Figure 1 Measurement setup for the nasal sound pressure method. The amplitude-modulated driver stage, including the Agilent 35670A, the Agilent 33220A, and the
transmitter inductive link, is driving the implant. The nasal sound pressure is measured by a microphone with a pre-ampliﬁer and is analyzed by the Agilent 35670A.
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study11 showed that breathing gives a turbulent sound pres-
sure response, therefore subjects were instructed not to
breathe during the measurements in the follow-up visits.
Given the short duration of the whole procedure (approxi-
mately 20 seconds), patients were considered able to
accomplish the task of holding their breath.
Calculations
In order to generate the frequency response in dB rel 20 µPa/N
(dB SPL at 1N stimulation), calibrations of the BCI transdu-
cer and the probe tube microphone were performed. The
response from the transducer in the BCI was calibrated
using the Skull Simulator TU-1000 (Nobelpharma,
Göteborg, Sweden) to output force level.12 The probe tube
microphone was calibrated using a Brüel & Kjær (Brüel &
Kjær Sound and Vibration Measurement A/S, Nærum,
Denmark) type 4134 ½-inch microphone. The sensitivity
of the microphone was determined with a Brüel & Kjær
type 4230 sound level calibrator. Then the probe tube open-
ing was placed 1 mm from the ½-inch microphone, a sound
ﬁeld was introduced, and the calibration curve of the probe
tube microphone was obtained for the frequency range
0.1–10 kHz.
The time analysis was based on those patients where all
data were available, thus excluding two patients who missed
the 3 month and the 12 month follow-up visit, respectively.
The NSP data from the eleven patients used were ﬁtted with
a linear mixed effects (LME)model.13 This model was chosen
over a standard linear regressionmodel in order to consider the
grouping structure of the collected data, given the fact that
subsequent measurements were performed on the same
patients. Observations from the same individual at different
visits are expected to have a higher degree of similarity than
observations from different individuals at the same visit, and
the data should therefore be grouped according to the patients’
ID and not only according to the time of measurement. The
grouping structure would have been totally ignored in
a standard regression model, where the information about
individual subjects’ trends is lost in the pooling process. In
this study, each set of measurements taken from the same
patient belongs to the same group, giving a total of eleven
groups with ﬁve observations in each. By using mixed effects
models, it was possible to perform a conventional linear
regression, while still accounting for some extra variability
associated with individual subjects. This leads to a model
consisting of some ﬁxed effects terms, describing the whole
statistical population, and some random effects terms, which
are associated with the individuals.
In order to reduce the between-subject variability, data
points were expressed as variation from the initial value,
ie, the NSP-value at ﬁtting (baseline). The utilized model
is then given by:
Yij ¼ mþ k  ti þ βj  ti þ i
where Yij is the NSP measured at observation i for subject
j expressed as variation from the baseline for patient j,
i=1:5 (measurement number), j=1:11 (subject ID), ti=0, 1,
3, 6, 12 months (independent variable), m is the overall
intercept, k is the overall slope, and βj is a subject-speciﬁc
parameter, which is assumed to be random, ie, for each
subject the values are drawn from a normal distribution,
and ϵi~N(0,σ) is the residual error.
With this model, it was possible to identify general
trends common to all subjects by looking at the overall
intercept (m) and slope (k). Studying the random para-
meter ðβjÞ gave the possibility to identify any subject
showing a trend deviating from the average.
The following assumptions were made and veriﬁed on
the data in order to legitimate the use of an LME model: 1)
normal distribution of the data samples, 2) independency
and constant variance of the residuals (modeled value
subtracted from observed data), 3) normal distribution of
the residuals, and 4) normal distribution of random effects.
MATLAB (MathWorks Inc, Natick, MA, USA) was used
to read and organize data in matrices, and R (R Core Team
(2016), Vienna, Austria) was used for the statistical analysis.
The model was ﬁtted with the lme4 package14 and the statis-
tical signiﬁcance was obtained from the t-values generated
by the utilized lmer ﬁtting function with 55–2=53 degrees of
freedom, where 55 is the total number of observations (ele-
ven subjects with ﬁve observations each) and 2 is the number
of ﬁxed parameters included in the model (m and k). With
these degrees of freedom, an estimated parameter can be
deﬁned signiﬁcantly different from 0 at signiﬁcance level
α=5% (p<0.025) if the t-value is >2.0057.
All three model parameters were estimated for the key
frequencies 0.5, 1, 2, and 4 kHz, and the overall slope for
every measured frequency. The estimated overall slope (k)
was regarded as the main indicator of transmission stability
over time, where k=0 indicates unchanged transmission prop-
erties, while a positive or negative k value is associated with
an increased or decreased transmission, respectively.
Results
Figure 2 shows an example of a patient’s NSP for surgery and
all follow-up visits. The results are shown only for the
Reinfeldt et al Dovepress
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frequency interval 0.4–5 kHz, even though the measurements
were made for 0.1–10 kHz, because this is the approximate
frequency interval where the NSP is clearly above the micro-
phone noise ﬂoor for most patients. The results illustrated that
the intra-subject variability is relatively small when compar-
ing follow-up visit measurements, where the measurement
conditions are similar. At surgery, the NSP seems to show
a systematically different frequency dependence, which could
be attributed to the difference in measurement conditions, as
during surgery the patient is lying down anaesthetized with
a respiration tube down the trachea, while in follow-up visits
he/she is sitting and holding their breath.
In Figure 3, averages of follow-up NSPs for all patients
were plotted together with the group average, where
a large inter-subject variability can be seen.
The box plot in Figure 4 shows the distribution of data
measured at surgery for frequencies 0.5, 1, 2, and 4 kHz. The
ﬁgure shows maximum and minimum values, 25th and 75th
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Figure 2 The nasal sound pressure for patient 12 at surgery, ﬁtting, and follow-up visits at 1, 3, 6, and 12 months after ﬁtting. The noise ﬂoor from surgery is also presented.
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Figure 3 Average nasal sound pressure level based on follow-up data for each patient (in colors) together with the overall mean (black solid line) and the average noise ﬂoor
(black dotted line).
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percentiles, average and median values. This representation
was provided in order to get an estimate of the expected
value when a new patient is measured at surgery.
The analysis of NSP data variability over time with the
LME model at 500 Hz, 1, 2, and 4 kHz is summarized in
Table 1 and shown in Figures 5 and 6. Overall intercept (m)
quantiﬁes the variation in baseline values, overall slope (k) is
associated with stability over time, and random effect is the
subject-speciﬁc parameter. Subject-speciﬁc slopes represent
individual variations from the average slope k, they are
modeled as normally distributed random variables, each
with a certain mean, resulting in eleven different values
(one for each subject) that would superimpose to the overall
k to describe each subject singularly. t-values >2.0057 indi-
cate a signiﬁcant deviation from 0 at 5% conﬁdence level:
a condition that is not satisﬁed for any of the estimated
parameters. Figure 5 shows the data points and their linear
interpolation with a general slope and intercept (the ﬁxed
effects of the LME model). Figure 6 is a so-called caterpillar
plot of the subject-speciﬁc slopes estimates (the random
effect of the LME model). This ﬁgure, side-by-side, plots
the eleven parameters (one for each subject) with their 95%
CIs in order to facilitate the visualization and comparison of
subject-speciﬁc trends. Those whose CI does not include 0
100
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Figure 4 Boxplot of the nasal sound pressure of all patients at surgery at frequencies 0.5, 1.0, 2.0, and 4.0 kHz, showing average (*), median (red line), 25 and 75 percentiles
(blue box), and minimum and maximum values (whiskers).
Table 1 Summary of results from model ﬁtting. For the selected frequencies, a summary of the estimated ﬁxed effects with their
standard error for the linear mixed effects model is given. t-values >2.0057 indicate a signiﬁcant deviation from 0 (α=5%)
Estimate Standard error t-value
500 Hz Overall intercept (m) 1.005 1.010 0.995
Overall slope (k) −0.008 0.184 −0.044
1,000 Hz Overall intercept (m) 1.807 1.017 1.777
Overall slope (k) 0.010 0.225 0.045
2,000 Hz Overall intercept (m) −0.274 0.655 −0.419
Overall slope (k) −0.027 0.146 −0.182
4,000 Hz Overall intercept (m) 1.010 1.219 0.828
Overall slope (k) 0.467 0.286 1.634
Reinfeldt et al Dovepress
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are considered as signiﬁcantly deviating from the group
average at 5% conﬁdence level.
The overall slope estimates (k values) are around zero,
indicating stable transmission over time, with an exception
for the value at 4 kHz, which is slightly higher. However,
a further analysis of k over all the frequencies (Figure 7)
shows that this is the absolute highest peak value of the
whole frequency interval.
Discussion
In summary, the analysis in this study has shown: 1) that
NSP could be used to verify the implant's functionality
during surgery, 2) large inter-subject and small intra-
subject variations, 3) stability of NSP over time
(12 months), and 4) difference between various measure-
ment conditions (surgery vs follow-up).
The stability of NSP over time indicates that the trans-
mission to bone has not changed over time. In a few
frequencies, the transmission could even be interpreted as
giving a slight increase in transmission (eg, 0.47 dB per
month at 4 kHz), which in turn could be interpreted as
osseointegration.
In the time analysis, the authors chose to include only
patients where data from all follow-up visits were avail-
able. An alternative (also including the data from the two
remaining patients) would have been to interpolate their
missing values, or to estimate slopes ignoring the missing
500 Hz 1000 Hz 2000 Hz 4000 Hz
y = 0.01x +1.807y = -0.008x +1.005 y = 0.027x -0.274
1 3 6 12 1 3 6 12 1 3 6 12 1 3 6 12
Time from fitting [months]
N
S
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el
in
e 
[d
B
]
Figure 5 Linear model of the nasal sound pressure over time relative to baseline (ﬁtting) at four frequencies with the respective equation showing slope and intercept.
500 Hz 1000 Hz 2000 Hz 4000 Hz
(*) (*)
(*)
(*)10
8
5
11
12
4
13
7
1
9
1
10
5
12
4
2
11
7
13
8
1
5
13
9
8
7
4
12
2
11
10
8
4
7
10
2
13
11
1
9
12
5
P
at
ie
nt
 ID
9
2
-1.0 0.0 1.0-0.5 0.0 0.5 0.0 1.0 1.5 -0.5 0.0 0.5-1
Individual random effect size [dB/month]
Figure 6 Random effects visualization: for each patient included in the analysis, the individual k-value is estimated with its 95% CI. Intervals not including 0 indicate that the
patient has a signiﬁcant deviation from the overall slope (group average), marked with a red asterisk.
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time points. In a comparison with the analysis performed
in this article, interpolation to ﬁll in the missing 3 month
and 6 month data was done with the result that the k value
was very similar with no statistically signiﬁcant differ-
ences from the presented results.
The decision to use a ﬁrst order linear model was made
mainly to keep the model as simple as possible. A second
order linear model was ﬁtted for comparison purpose.
Adding a quadratic term (ti
2) to the ﬁrst order formula,
the following model was obtained:
Yij ¼ mþ k  ti þ k2  t2i þ βj  ti þ i
where k2 is the overall quadratic term coefﬁcient at time ti,
and the other parameters are as deﬁned in the data analysis
section. Fitting the data with this second order model
resulted in two drawbacks: 1) the complexity of the
model increased, with one extra parameter to be estimated
(k2), resulting in no apparent beneﬁt in the quality of the ﬁt
when evaluated with the Akaike Information Criterion
(AIC). The AIC by Akaike15 is an estimator used to
compare the adequacy of two or more models relative to
each other, and is often used to choose between different
options to ﬁt a speciﬁc set of data; 2) the second order
model for all frequencies besides 500 Hz showed
a downwards parabolic shape, giving the impression of
a decline in NSP after 6 months. This behavior is due to
the fact that the data point at 12 months follow-up
was lower than the one at 6 months follow-up. However,
the authors believe that such an interpretation would be
misleading, and hypothesize that the slight decrease of the
NSP value at 12 months follow-up indicates the NSP
reaching a plateau. An analysis of data for those patients
who had their device for more than 36 months conﬁrms
this hypothesis. However, data from a longer time span
needs to be collected before being able to estimate the
long-term behavior of NSP.
One aim of this study was to investigate whether this
method is suitable as objective veriﬁcation of the implant
during surgery and during follow-up visits. Based on our
experience with these measurements, the results provided
valid and reliable measurement of the implant's function-
ality and the transmission was stable over time. However,
this measurement technique requires some technical setup,
possibly too much for a standard clinical setup. On the
other hand, some clinics also performing middle-ear
implantation would already be equipped with such instru-
mentation, given that they use insert microphones in their
patients’ ears or on the forehead to guide the surgery and
to optimize the implant coupling, according to Schnabl
et al9 and Ghoncheh et al.10 Lately, a new, so-called, sur-
face microphone approach has been developed with the
objective of verifying ﬁtting of BCDs.16 This approach has
some advantages over the nasal sound probe, since it does
not require the patients to hold their breath during the
measurement and is easier to apply to patients.
As a subjective evaluation, the sound from radiation into
the surrounding air could be listened to, but for an objective
evaluation, the NSP method has been shown to be a reliable
alternative. In an attempt to estimate the NSP for new
patients during surgery, Figure 4 shows the distribution of
NSP at a few speciﬁc frequencies. To conclude, most values
above the noise ﬂoor indicate a functioning implant. Hence,
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Figure 7 Slope value (k) as a function of frequency. Asterisks (*) mark the values at the audiometric frequencies.
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to verify the implant's functionality, a simpler solution
should be enough. However, to be able to follow the trans-
mission to bone and the implant's functionality over time,
measuring the NSP from electric stimulation appears to be
an appropriate method.
As can be seen in Figure 2, the NSP during surgery in
general varies from the follow-up NSP. This is hypothesized
to depend on the measurement situation. To investigate this,
pilot NSP measurements were made on normal-hearing sub-
jects in various situations: in sitting and laying positions,
directing the face straight ahead and to the side, and holding
the breath in different ways (with open and closed mouth,
and by closing the trachea with the larynx or by closing the
soft palate between nasopharynx and oropharynx). All these
ways were used in an attempt to estimate the difference
between the surgery setting, where the patient is anesthetized
with a tube in the trachea, and the follow-up measurements,
where the patient is sitting, holding their breath. However, no
trends showing similarity to the surgery vs follow-up differ-
ence has been found in these pilot measurements. Hence, the
authors are not able to explain this difference, except that it is
somehow related to the measurement conditions.
Another application of the NSP method may be to verify
the functionality after accidents, ie, if the implant has been
exposed to external forces, or after performing magnetic
resonance imaging (MRI). Even though the implant of the
BCI should withstand MRI up to 1.5 Tesla, in this clinical
study it had to be removed prior to MRI, since more testing
against American Standard for Testing Materials standards is
required for ﬁnal approval.17
In the literature, there are rare ﬁndings of studies where
NSP is investigated and there are no data to compare the
results of this study with. The two main application areas
were judgements of nasality and measurement of noise from
ventilation in intensive care. In judgements of nasality, oral
and NSP levels were measured and the ratios used as
a measure of nasality, as ﬁrst suggested by Shelton et al.18
To investigate noise from different ventilation equipment in
neonates in intensive care, sound pressure was measured in
the entrance of the nostrils and further down in the post-
nasal space by Surenthiran et al.19 In both applications,
probe tube microphones were used, and apparently without
plugging the nostril, though plugging was performed in this
study. The reason for plugging the nostril in this study was to
reduce the inﬂuence of surrounding noise, thereby accom-
plishing more reliable and repeatable results.
A restriction in the results is that the noise ﬂoor of the
microphone keeps the NSP valid only for a limited
frequency range of 0.4–5 kHz. Therefore, the lowest and
highest frequencies of the measurements have been left out
in this paper. However, the authors do not consider this
a major limitation, because the mid-frequency range is, in
practice, the most important one that is picked-up by hearing
aids.
Conclusion
The NSP under electrical stimulation of the implant was
investigated in 13 patients with BCI in a clinical study. The
NSP method was found suitable as objective veriﬁcation of
the BCI implant. It was concluded that the NSP is individua-
lized with a large variability between patients, but also low
variability within subjects during follow-up measurements.
A difference was found between the NSPmeasured at surgery
and at follow-up visits, probably due to different measurement
conditions. The NSP, and hence the transmission to bone and
implant functionality, were found to be stable over time.
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